Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.94 |
| ▸ | HPGD | P15428 | 4/20 | 0.94 |
| ▸ | GLA | P06280 | 2/20 | 0.94 |
| ▸ | ACHE | P22303 | 1/20 | 0.94 |
| ▸ | NQO2 | P16083 | 4/20 | 0.68 |
| ▸ | HTR3A | P46098 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.55 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acridine SCHEMBL4972293 | 0.97 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL8339 | 0.97 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL3045498 | 0.97 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL1772714 | 0.97 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL29352289 | 0.97 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDGLAACHE | |
| Anthracene SCHEMBL9879830 | 0.94 | MAPT (0.94) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL2401648 | 0.94 | ALDH1A1 (0.94) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL5182487 | 0.94 | ALDH1A1 (0.94) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL2394207 | 0.94 | ALDH1A1 (0.94) | MAPTALDH1A1HPGDGLAACHE | |
| Acridine SCHEMBL641951 | 0.94 | ALDH1A1 (0.94) | MAPTALDH1A1HPGDGLAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302708-A | Virtual image display device, head-up display system, and transport machine | 富士胶片株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118202811-A | Organic EL display device | 富士胶片株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117980789-A | Liquid crystal composition, liquid crystal cured layer, optical film, polarizing plate, and image display device | 富士胶片株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-117280260-A | Light absorbing anisotropic layer, optical film, viewing angle control system, and image display device | 富士胶片株式会社 | 2023-12-22 | — | — | CN | disclosed |
| US-20230157163-A1 | ORGANIC COMPOUND, PREPARATION METHOD THEREOF, AND DISPLAY PANEL | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| US-20230157163-A1 | ORGANIC COMPOUND, PREPARATION METHOD THEREOF, AND DISPLAY PANEL | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2023-05-18 | — | — | US | disclosed |
| CN-113072554-A | Organic compound, manufacturing method thereof and display panel | 武汉华星光电半导体显示技术有限公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-113072554-A | Organic compound, manufacturing method thereof and display panel | 武汉华星光电半导体显示技术有限公司 | 2021-07-06 | — | — | CN | disclosed |
| EP-2074126-A2 | SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF | Wyeth a Corporation of the State of Delaware (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008049105-A2 | SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF | WYETH (US) | 2008-04-24 | — | — | WO | disclosed |
| WO-2002089799-A2 | USE OF DIHYDROPYRAZOLES TO INCREASE ERYTHROPOIETIN AND VASCULARI ZATION | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| EP-1165530-A2 | DIHETERO-SUBSTITUTED METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001070690-A1 | HETEROCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001070682-A2 | CARBOCYCLIC SIDE CHAIN CONTAINING METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001070691-A1 | HETEROCYCLIC SIDE CHAIN CONTAINING, N-SUBSTITUTED METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001070720-A2 | CARBOCYCLIC SIDE CHAIN CONTAINING, N-SUBSTITUTED METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2000051993-A2 | DIHETERO-SUBSTITUTED METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| US-5972536-A | ANODE PREPARED BY CARBONIZING A SAMPLE OF A PLANT ORIGIN HIGH MOLECULAR WEIGHT MATERIAL; PULVERIZING SAID CARBONIZED SAMPLE AND SINTERING THE PULVERIZED PRODUCT BY HEATING THE PRODUCT IN A VACUUM OR AN INERT GAS ATMOSPHERE | SONY CORPORATION (JP) | 1999-10-26 | — | — | US | disclosed |
| US-5834138-A | MIXTURE OF CELLULOSE WITH METAL, PHOSPHORUS OR SULFUR DOPES | SONY CORPORATION (JP) | 1998-11-10 | — | — | US | disclosed |
| EP-0758801-A1 | NEGATIVE ELECTRODE MATERIAL FOR SECONDARY CELL FOR NONAQUEOUS ELECTROLYTIC SOLUTION, PROCESS FOR THE PRODUCTION THEREOF, AND SECONDARY CELL FOR NONAQUEOUS ELECTROLYTIC SOLUTION USING IT | SONY CORPORATION (JP) | 1997-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157163-A1 | ORGANIC COMPOUND, PREPARATION METHOD THEREOF, AND DISPLAY PANEL | HTR4, AR, HTR2C | MAPT 3226/4885ALDH1A1 150/4885HPGD 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.